[go: up one dir, main page]

LV5765B4 - Method for obtaining (S) - (-) - 1-propyl-2 ', 6'-pipecoloxylid hydrochloride monohydrate and its pharmaceutical preparation - Google Patents

Method for obtaining (S) - (-) - 1-propyl-2 ', 6'-pipecoloxylid hydrochloride monohydrate and its pharmaceutical preparation

Info

Publication number
LV5765B4
LV5765B4 LV960261A LV960261A LV5765B4 LV 5765 B4 LV5765 B4 LV 5765B4 LV 960261 A LV960261 A LV 960261A LV 960261 A LV960261 A LV 960261A LV 5765 B4 LV5765 B4 LV 5765B4
Authority
LV
Latvia
Prior art keywords
pipecoloxylid
propyl
obtaining
pharmaceutical preparation
hydrochloride monohydrate
Prior art date
Application number
LV960261A
Other languages
Latvian (lv)
Other versions
LV5765A4 (en
Inventor
Rune Verner Sandberg
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20363001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV5765(B4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of LV5765A4 publication Critical patent/LV5765A4/en
Publication of LV5765B4 publication Critical patent/LV5765B4/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LV960261A 1986-01-03 1996-07-17 Method for obtaining (S) - (-) - 1-propyl-2 ', 6'-pipecoloxylid hydrochloride monohydrate and its pharmaceutical preparation LV5765B4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8600017A SE451840B (en) 1986-01-03 1986-01-03 OPTICALLY PURE MONOHYDRATED OF S - (-) - 1-PROPYL-2 ', 6'-PIPECOLOXYLIDE HYDROCHLORIDE, SET TO PREPARE THIS AND PHARMACEUTICAL PREPARATIONS FOR LOCAL ANCHORING
EP86850440A EP0239710B1 (en) 1986-01-03 1986-12-15 (s)-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it

Publications (2)

Publication Number Publication Date
LV5765A4 LV5765A4 (en) 1996-12-20
LV5765B4 true LV5765B4 (en) 1997-06-20

Family

ID=20363001

Family Applications (1)

Application Number Title Priority Date Filing Date
LV960261A LV5765B4 (en) 1986-01-03 1996-07-17 Method for obtaining (S) - (-) - 1-propyl-2 ', 6'-pipecoloxylid hydrochloride monohydrate and its pharmaceutical preparation

Country Status (29)

Country Link
US (1) US4870086A (en)
EP (1) EP0239710B1 (en)
JP (1) JPH07598B2 (en)
KR (1) KR940008302B1 (en)
AR (1) AR242561A1 (en)
AT (1) ATE56956T1 (en)
AU (1) AU592392B2 (en)
BG (1) BG62066B2 (en)
CA (1) CA1276154C (en)
CY (1) CY1680A (en)
DE (1) DE3674582D1 (en)
DK (1) DK171378B1 (en)
EG (1) EG17867A (en)
ES (1) ES2036179T3 (en)
FI (1) FI83075C (en)
GR (1) GR3002516T3 (en)
HK (1) HK5493A (en)
IE (1) IE59061B1 (en)
LU (1) LU88843I2 (en)
LV (1) LV5765B4 (en)
MY (1) MY101132A (en)
NL (1) NL960005I2 (en)
NO (2) NO170330C (en)
NZ (1) NZ218615A (en)
PH (1) PH22924A (en)
PT (1) PT84041B (en)
SE (1) SE451840B (en)
SG (1) SG117292G (en)
ZA (1) ZA868600B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018897A1 (en) * 1990-06-07 1991-12-12 The Wellcome Foundation Limited Therapeutic heterocyclic compounds
ES2082703B1 (en) * 1993-11-04 1996-12-16 Inst Investigacion Desarrollo NEW DERIVATIVES OF CYCLOPROPIL, PROCEDURES FOR ITS PREPARATION AND APPLICATIONS.
US5834490A (en) * 1993-11-04 1998-11-10 Instituto De Investigacion Y Desarrolo Quimico Biologico, S.A. Cyclopropyl derivatives, preparation method there-of and applications
DE69525950T2 (en) * 1994-09-23 2002-09-19 Darwin Discovery Ltd., Cambridge RACEMIZATION PROCESS IN THE PRODUCTION OF LEVOBUPIVACAINE AND ANALOGS
SE9501808D0 (en) * 1995-05-16 1995-05-16 Astra Ab New process
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
SE9800139D0 (en) 1998-01-21 1998-01-21 Astra Ab New use
BRPI0104491B8 (en) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide; process of obtaining the enantiomers; non-racemic mixture of anantiomers and its process of obtaining and pharmaceutical composition.
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US7683175B2 (en) * 2005-06-06 2010-03-23 Navinta, Llc Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom
US20090187024A1 (en) * 2006-04-25 2009-07-23 Dishman Pharmaceuticals And Chemicals Ltd. Ropivacaine hydrochloride anhydrate and the preparation thereof
PT2234974E (en) * 2008-01-15 2012-05-29 Pharmathen Sa Process for the preparation of (s)-1-alkyl-2`,6`-pipecoloxylidide compound
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
CN102093284B (en) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 Method for enriching piperidine-2-formanilide optically active compound

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2248018A (en) * 1939-03-30 1941-07-01 Winthrop Chem Co Inc 4-aryl-piperidine-ketones and a process of preparing them
GB775749A (en) * 1955-04-06 1957-05-29 Bofors Ab Method of preparing amides of n-alkyl piperidine monocarboxylic acid and n-alkyl pyrrolidine -a-monocarboxylic acid
GB775750A (en) * 1955-04-28 1957-05-29 Bofors Ab Method of preparing amides of n-alkyl piperidine mono-carboxylic acid and n-alkyl pyrrolidine -a-monocarboxylic acid
US2799679A (en) * 1955-04-28 1957-07-16 Bofors Ab Process of preparing amides of heterocyclic carboxylic acids
GB800565A (en) * 1956-01-23 1958-08-27 Bofors Ab Method of producing n-alkyl-piperidine-ª‡-monocarboxylic acid amides and n-alkyl-pyrrolidine-ª‡-monocarboxylic acid amides
GB824542A (en) * 1957-05-15 1959-12-02 Bofors Ab Method of producing n-alkyl-piperidine-alpha-monocarboxylic acid amides
GB869978A (en) * 1958-03-13 1961-06-07 Bofors Ab Method of producing n-alkyl-and-cycloalkyl-piperidine carboxylic acid amides
GB949729A (en) * 1960-11-15 1964-02-19 Bofors Ab Substituted-piperidine carboxylic acid amide salts and their preparation
SE341404B (en) * 1967-05-18 1971-12-27 Sterling Drug Inc
CH491915A (en) * 1967-06-28 1970-06-15 Geigy Ag J R Process for the preparation of new piperidine derivatives
US3879382A (en) * 1971-08-27 1975-04-22 Teijin Ltd Process for the recovery of D- or L-{60 -amino-{68 -caprolactam hydrochloride of enhanced optical purity from mixtures of D- and L-{60 -amino-{68 -caprolactam hydrochloride
SE7607114L (en) * 1976-06-22 1977-12-23 Bofors Ab METHOD OF PREPARING THE HYDROCHLORIDE OF N-METHYLPIPERIDINE-2-CARBONIC ACID-2,6-XYLLIDIDE
SE431092B (en) * 1979-07-10 1984-01-16 Thuresson Af Ekenstam Bo THERAPEUTICALLY ACTIVE, SUBSTITUTED PIPERIDINKARBOXIANILIDES
DE3379266D1 (en) * 1983-08-01 1989-04-06 Astra Laekemedel Ab L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same

Also Published As

Publication number Publication date
EP0239710A1 (en) 1987-10-07
JPH07598B2 (en) 1995-01-11
FI83075C (en) 1991-05-27
NO1997009I1 (en) 1997-08-18
PT84041A (en) 1987-01-01
SE8600017L (en) 1987-07-04
SG117292G (en) 1993-01-29
LU88843I2 (en) 1997-03-14
FI83075B (en) 1991-02-15
NO170330B (en) 1992-06-29
KR940008302B1 (en) 1994-09-12
EG17867A (en) 1991-03-30
DK287A (en) 1987-07-04
DE3674582D1 (en) 1990-10-31
JPS62158251A (en) 1987-07-14
NL960005I1 (en) 1996-09-02
NO864858L (en) 1987-07-06
NO864858D0 (en) 1986-12-03
ATE56956T1 (en) 1990-10-15
FI870003A0 (en) 1987-01-02
NZ218615A (en) 1989-07-27
LV5765A4 (en) 1996-12-20
NO170330C (en) 1992-10-07
MY101132A (en) 1991-07-31
GR3002516T3 (en) 1993-01-25
FI870003A (en) 1987-07-04
CY1680A (en) 1993-10-10
ZA868600B (en) 1987-08-26
AU592392B2 (en) 1990-01-11
SE451840B (en) 1987-11-02
IE870004L (en) 1987-07-03
ES2036179T3 (en) 1993-05-16
PT84041B (en) 1989-09-14
DK287D0 (en) 1987-01-02
DK171378B1 (en) 1996-10-07
US4870086A (en) 1989-09-26
CA1276154C (en) 1990-11-13
BG62066B2 (en) 1999-01-29
KR870007118A (en) 1987-08-14
PH22924A (en) 1989-01-24
IE59061B1 (en) 1993-12-15
NL960005I2 (en) 1997-10-01
HK5493A (en) 1993-01-29
EP0239710B1 (en) 1990-09-26
SE8600017D0 (en) 1986-01-03
AU6644986A (en) 1987-07-09
AR242561A1 (en) 1993-04-30

Similar Documents

Publication Publication Date Title
LV5760B4 (en) New pharmaceutical preparation for oral use
LV5765A4 (en) Method for obtaining (S) - (-) - 1-propyl-2 ', 6'-pipecoloxylid hydrochloride monohydrate and its pharmaceutical preparation
KR880005932A (en) Pharmaceutical composition for reducing neurotoxicity damage
DK52787D0 (en) PHARMACEUTICAL PREPARATION WITH PROTRAACTED EFFECTS AND PROCEDURES FOR PREPARING IT
FI891338A (en) Improvement of the process for the preparation of 2 ', 3'-dideoxy-2', 3'-didehydronucleosides
PH24749A (en) Piperidine compounds, pharmaceutical composition and method of use thereof
IT8922164A0 (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
IT8767057A0 (en) LONG-RELEASE PHARMACEUTICAL COMPOSITIONS, RELATIVE DOSAGE FORMS AND PROCEDURE FOR THEIR PREPARATION
FI894546A (en) Process for the preparation of new 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyladenosine derivatives
DK559288D0 (en) PHARMACEUTICAL PREPARATION FOR PIPERIDINOAL CHANNEL DERIVATIVES
IT8722264A0 (en) PROCEDURE FOR THE PREPARATION OF SOLUBLE AND/OR DIVISIBLE TABLETS AND TABLETS OBTAINED SO.
IT1196499B (en) PROCESS PERFECTED FOR THE PREPARATION OF BORICA DIOXIDE
IT1196528B (en) AZOLYL DERIVATIVES FOR ANTI-Fungal activity
HUT47849A (en) Process for producing new pharmaceutical with analgetic and hypertonicity-relaxing effect
DK624587D0 (en) PHARMACEUTICAL PREPARATION CONTAINING IMIDAZOLD DERIVATIVES
GB2195082B (en) Pharmaceutical preparation for veterinary use
DK173287D0 (en) PERHYDROTHIAZEPINE AND PERHYDROAZEPINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
IT1216894B (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION.
LV5752A4 (en) Pharmaceutical preparation and method for its production
IT1222591B (en) 1,4-DIHYDROPYRIDINS 2-ALCHIL- AND ALCHENYL-SUBSTITUTED, METHOD FOR THEIR PHARMACEUTICAL PREPARATION AND COMPOSITION CONTAINING THEM
IT1201174B (en) PHARMACEUTICAL SOLUTION INCLUDING L-3,4-DIHYDROXYPHENYL-ALPHA-METHYLALANINE CHELATES AND PROCEDURE FOR ITS PREPARATION
PT84557A (en) Process for the preparation of alkylaminofuranone derivatives and pharmaceutically acceptable salts thereof
SE8602975D0 (en) PHARMACEUTICAL PREPARATION
LV5818A4 (en) N, n-bis- (4-Fluorophenyl) carbamoylacethydroxamic acid and pharmaceutical composition thereof
PH22996A (en) Dichloroaniline derivatives, pharmaceutical composition containing said compound and method of use thereof